Comparative Study on Histochemical Expression of CD34 in Different Variants of Ameloblastoma: CD34 Expression in Ameloblastoma Variants

Nasiha Bashir; Maria Obaid; Fatima Iqbal; Hoor Maryam; Tehmina Naushin; Abbas Saleem Khan

doi:10.54393/pjhs.v6i1.2246

Authors

Nasiha Bashir Department of Oral Pathology, Peshawar Dental College / Riphah International University, Peshawar, Pakistan
Maria Obaid Department of Oral Pathology, Peshawar Dental College / Riphah International University, Peshawar, Pakistan
Fatima Iqbal Department of Oral Pathology, Peshawar Dental College / Riphah International University, Peshawar, Pakistan
Hoor Maryam Department of Oral Pathology, Peshawar Dental College / Riphah International University, Peshawar, Pakistan
Tehmina Naushin Department of Oral Pathology, Peshawar Dental College / Riphah International University, Peshawar, Pakistan
Abbas Saleem Khan Department of Oral Pathology, Peshawar Dental College / Riphah International University, Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i1.2246

Keywords:

Ameloblastoma, CD34 Expression, Mean Vascular Density, Histological Variants

Abstract

Ameloblastoma is a benign, locally aggressive, tumor of the oral cavity having a high propensity for recurrence. The growth potential of the tumor is linked to the proliferation of preexisting vasculature and is reflected in CD34 expression. has been rephrased as “Mean Vascular Density (MVD) which measures CD34 expression, aids in predicting this proliferation. Objectives: To evaluate the biological behavior of different variants of Ameloblastoma according to expression of CD34 and to correlate it with age and gender. Methods: The present study was analytical, cross-sectional study composed of total 40, already diagnosed cases of ameloblastoma. Immuno-histochemical expression of CD34 was analyzed. Results: Follicular variant has more growth potential in females 21 (62%) and males reveal more vascular growth in plexiform 19 (80%) acanthomatous (50%) and unicystic variant (50%). More endothelial proliferation in age group of > 40 years was seen in follicular variant, whereas, in age group of < 40 years, plexiform type was more dominant. However, relationship between the age groups and MVD scores were found to be insignificant (p > 0.05). Relationship between CD34 expression in ameloblastoma and its histological variants were also found to be statistically non-significant (p=0.9). Conclusions: All variants display highest Mean Vascular Density (MVD) score in posterior mandible. Follicular variant has more growth potential in females while in males it is found more in plexiform, acanthomatous and unicystic variants. More epithelial proliferation in the follicular variety is observed in the age group over 40, whereas more plexiform type was shown in the age group below 40.

References

Kondo S, Ota A, Ono T, Karnan S, Wahiduzzaman M, Hyodo T et al. Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma. Cancer Medicine. 2020 Apr; 9(8): 2904-17. doi: 10.1002/cam4.2931.

Bayat Z, Mirzaeian A, Taherkhani A. Potential biomarkers and signaling pathways associated with the pathogenesis of primary ameloblastoma: a systems biology approach. International Journal of Dentistry. 2022 Sep; 2022(1): 3316313. doi: 10.1155/2022/3316313.

Fuchigami T, Ono Y, Kishida S, Nakamura N. Molecular biological findings of ameloblastoma. Japanese Dental Science Review. 2021 Nov; 57: 27-32. doi: 10.1016/j.jdsr.2020.12.003.

Bi L, Wei D, Hong D, Wang J, Qian K, Wang H et al. A retrospective study of 158 cases on the risk factors for recurrence in ameloblastoma. International Journal of Medical Sciences. 2021; 18(14): 3326. doi: 10.7150/ijms.61500.

Evangelou Z, Zarachi A, Dumollard JM, Michel PH, Komnos I, Kastanioudakis I et al. Maxillary ameloblastoma: a review with clinical, histological and prognostic data of a rare tumor. In Vivo. 2020 Sep; 34(5): 2249-58. doi: 10.21873/invivo.12035.

Anwar Z and Susilo I. Clinicopathological profile of ameloblastoma: A retrospective study for 5-years. International Journal of Health Sciences. 2022; 6(5) (V): 478-85. doi: 10.53730/ijhs.v6nS5.7912.

Hafiza Shahzadi Maryam, Shamsul Hadi, Fazal Hanan, Humaira Saif and Alamgir. Assessment of Angiogenesis in Ameloblastoma: A Comparison Base on Patient Age. International Journal of Clinical Studies & Medical Case Reports. 2022; 20(5). doi: 10.46998/IJCMCR.2022.20.000496.

Ibrahim A, Alqalshy E, Abdel-Hafiz AA, El-Rahman KA, Alazzazi M. Roles of Proliferation and Angiogenesis in Locally Aggressive Biologic Behavior of Ameloblastoma versus Ameloblastic Fibroma. Diagnostics. 2022 Feb; 12(2): 392. doi: 10.3390/diagnostics12020392.

Krenning G, Strate BV, Schipper M, van Seijen XG, Fernandes BC, van Luyn MJ et al. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. Journal of Cellular and Molecular Medicine. 2009 Aug; 13(8b): 2521-33. doi: 10.1111/j.1582-4934.2008.00479.x.

Hughes MR, Hernaez DC, Cait J, Refaeli I, Lo BC, Roskelley CD et al. A sticky wicket: defining molecular functions for CD34 in hematopoietic cells. Experimental Hematology. 2020 Jun; 86: 1-4. doi: 10.1016/j.exphem.2020.05.004.

de Mendonça RP, Balbinot KM, Martins BV, da Silva Kataoka MS, Mesquita RA, de Jesus Viana Pinheiro J et al. Hypoxia and proangiogenic proteins in human ameloblastoma. Scientific Reports. 2020 Oct; 10(1): 17567. doi: 10.1038/s41598-020-74693-7.

Maryam HS and Hadi S. Quantitative Evaluation of Mean Vascular Density using CD34 as Immunohistochemical Marker in Variants of Ameloblastoma. International Journal of Pathology. 2022 Jul-Sep: 121-6.

Pereira T, Dodal S, Tamgadge A, Bhalerao S, Tamgadge S. Quantitative evaluation of microvessel density using CD34 in clinical variants of ameloblastoma: An immunohistochemical study. Journal of Oral and Maxillofacial Pathology. 2016 Jan; 20(1): 51-8. doi: 10.4103/0973-029X.180929.

Maisa O Al-Sebaei SAA, Sara K Akeel, Ali S Sawan, Wafaey M Gomaa. Characteristics of Ameloblastoma with Immunohistochemical Study. Journal of Research in Medical and Dental Science. 2022; 10(7): 79-86.

Bwambale P, Yahaya JJ, Owor G, Wabinga H. Histopathological patterns and biological characteristics of ameloblastoma: A retrospective cross-sectional study. Journal of Taibah University Medical Sciences. 2022 Feb; 17(1): 96-104. doi: 10.1016/j.jtumed.2021.09.007.

Nazir H and Usman I. Prevalence of Ameloblastoma and its clinical and histopathological features: A retrospective study. European Journal of Pharmaceutical and Medical Research. 2019 Apr; 6: 1-4.

Hosseini S, Behjati F, Rahimi M, Taheri N, Khorshid HK, Moghaddam FA et al. Relationship between PIK3CA amplification and P110α and CD34 tissue expression as angiogenesis markers in Iranian women with sporadic breast cancer. Iranian Journal of Pathology. 2018 Sep; 13(4): 447.

Bashir N, Asif M, Malik IS, Araa N, Rashid F, Uddin H et al. Frequency of expression of BRAF V600E and epidermal growth factor receptor (EGFR) in Ameloblastoma. Asian Pacific Journal of Cancer Biology. 2022 Mar; 7(1): 29-35. doi: 10.31557/apjcb.2022.7.1.29-35.

Vila S, Oster RA, James S, Morlandt AB, Powell KK, Amm HM. A Retrospective Analysis of 129 Ameloblastoma Cases: Clinical and Demographical Trends from a Single Institution. Journal of Racial and Ethnic Health Disparities. 2024 Apr: 1-9. doi: 10.1007/s40615-024-01993-3.

Chaudhary Z, Krishnan S, Sharma P, Sharma R, Kumar P. A review of literature on ameloblastoma in children and adolescents and a rare case report of ameloblastoma in a 3-year-old child. Craniomaxillofacial Trauma & Reconstruction. 2012 Sep; 5(3): 161-8. doi: 10.1055/s-0032-1313358.

Maqsood A, Ali A, Zaffar Z, Mokeem S, Mokeem SS, Ahmed N et al. Expression of CD34 and α-SMA markers in oral squamous cell carcinoma differentiation. A histological and histo-chemical study. International Journal of Environmental Research and Public Health. 2021 Jan; 18(1): 192. doi: 10.3390/ijerph18010192.

Jamshidi S, Zargaran M, Baghaei F, Shojaei S, Mahmoodabadi RZ, Dehghan A et al. An immunohistochemical survey to evaluate the expression of CD105 and CD34 in ameloblastoma and odontogenic keratocyst. Journal of Dentistry. 2014 Dec; 15(4): 192.

Jehan R, Asher T, Adeel M, Shoaib M, Rizwan M, Jabeen N et al. Radiographical and Clinical Features of Ameloblastoma among patients Visiting the Tertiary Care Hospital. Pakistan Journal of Medical & Health Sciences. 2022 Jun; 16(05): 183-. doi: 10.53350/pjmhs22165183.

Farhan F, Niazi Z, Masood S, Abbas B. Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma. Pakistan Journal of Medical Sciences. 2022 Jan; 38(1): 207. doi: 10.12669/pjms.38.1.4465.

Ranchod S, Titinchi F, Behardien N, Morkel J. Ameloblastoma of the mandible: analysis of radiographic and histopathological features. Journal of Oral Medicine and Oral Surgery. 2021; 27(1): 6. doi: 10.1051/mbcb/2020051.

Anyanechi CE and Shetty SS. Ameloblastoma of the jaws in adult: A retrospective review of local recurrent lesions based on the resection margin in the adjacent apparent healthy tissues. Heliyon. 2023 May; 9(5). doi: 10.1016/j.heliyon.2023.e16243.

Chaisuparat R, Yodsanga S, Montaner S, Jham BC. Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2013 Sep; 116(3): 336-42. doi: 10.1016/j.oooo.2013.06.013.

Niranjan KC and Shaikh Z. Clinicopathological correlation of odontogenic cysts and tumours in a South Indian population over a 20-year period. Lateral. 2014; 2(1.5): 1. doi: 10.14419/ijdr.v2i2.1590.

Sherlin HJ, Natesan A, Ram P, Ramani P, Thiruvenkadam C. Immunohistochemical profiling of ameloblastomas using cytokeratin, vimentin, smooth muscle actin, CD34 and S100. Annals of Maxillofacial Surgery. 2013 Jan; 3(1): 51-7. doi: 10.4103/2231-0746.110084.

Seifi S, Shafaie S, Ghadiri S. Microvessel density in follicular cysts, keratocystic odontogenic tumours and ameloblastomas. Asian Pacific Journal of Cancer Prevention. 2011 Jan; 12(2): 351-6.

Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Research. 2000 Mar; 60(5): 1388-93.

Younis WH, Garib BT, Ala'a GH. Immunohistochemical Coexpression of VEGF and CD34 in Ameloblastoma. Journal of the Faculty of Medicine Baghdad. 2008 Apr; 50(1): 42-9. doi: 10.32007/jfacmedbagdad.5011300.

Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad‐Moghadam S. Comparison of angiogenesis in keratocystic odontogenic tumours, dentigerous cysts and ameloblastomas. Oral Diseases. 2009 Sep; 15(6): 422-7. doi: 10.1111/j.1601-0825.2009.01566.x.

Hande AH, Gadbail AR, Sonone AM, Chaudhary MS, Wadhwan V, Nikam A. Comparative analysis of tumour angiogenesis in solid multicystic and unicystic ameloblastoma by using CD 105 (endoglin). Archives of Oral Biology. 2011 Dec; 56(12): 1635-40. doi: 10.1016/j.archoralbio.2011.06.007.

Koizumi Y, Kauzman A, Okada H, Kuyama K, McComb RJ, Yamamoto H. Assessment of proliferative activity and angiogenesis in ameloblastoma: A comparison based on patient age. International Journal of Oral-Medical Sciences. 2004; 3(1): 25-33. doi: 10.5466/ijoms.3.25.